Literature DB >> 33654876

A Novel Protocol to Generate Decellularized Bovine Spinal Cord Extracellular Matrix-Based Scaffolds (3D-dCBS).

Yavuz E Arslan1, Burcu Efe1, Tugba Sezgin Arslan1.   

Abstract

Extracellular matrix (ECM)-based tissue engineering scaffolds have an essential role in promoting tissue regeneration. Nerve tissue engineering aims at facilitating the repair of permanent damage to the peripheral and central nervous systems, which are difficult to heal. For this purpose, a variety of biomaterials are being developed consisting of numerous synthetic and/or natural polymers to provide axonal reinnervation and to direct the growth of axons. Here, we present a novel protocol that enables to fabricate a 3-dimensional (3D) decellularized scaffold derived from the bovine spinal cord (BSC) ECM (3D-dCBS) for neural tissue engineering applications. In this protocol, a viscous ECM-derived gel from BSC is prepared, molded, and chemically crosslinked with EDC/NHS (3D-CBS) before decellularization process. Decellularization of 3D-CBS is performed with 1% SDS to attain 3D-dCBS. As compared with other available methods, our protocol is a novel decellularization method that preserves a more significant part of the ECM. We believe that the mentioned protocol has the potential to produce a bioengineered scaffold from spinal cord tissue with desired geometry for regenerative medicine applications related to neural tissue engineering.
Copyright © 2019 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Bovine spinal cord; Decellularized nerve scaffold; Neural graft; Regenerative medicine; Tissue reconstruction

Year:  2019        PMID: 33654876      PMCID: PMC7854014          DOI: 10.21769/BioProtoc.3380

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  22 in total

1.  A novel method for constructing an acellular 3D biomatrix from bovine spinal cord for neural tissue engineering applications.

Authors:  Yavuz Emre Arslan; Burcu Efe; Tugba Sezgin Arslan
Journal:  Biotechnol Prog       Date:  2019-04-19

2.  Electrospinning of collagen and elastin for tissue engineering applications.

Authors:  L Buttafoco; N G Kolkman; P Engbers-Buijtenhuijs; A A Poot; P J Dijkstra; I Vermes; J Feijen
Journal:  Biomaterials       Date:  2005-08-19       Impact factor: 12.479

3.  Fall-induced spinal cord injury: External causes and implications for prevention.

Authors:  Yuying Chen; Ying Tang; Victoria Allen; Michael J DeVivo
Journal:  J Spinal Cord Med       Date:  2015-04-01       Impact factor: 1.985

Review 4.  Biomaterial technology for tissue engineering applications.

Authors:  Yasuhiko Tabata
Journal:  J R Soc Interface       Date:  2009-03-04       Impact factor: 4.118

5.  Fabrication of human hair keratin/jellyfish collagen/eggshell-derived hydroxyapatite osteoinductive biocomposite scaffolds for bone tissue engineering: From waste to regenerative medicine products.

Authors:  Yavuz Emre Arslan; Tugba Sezgin Arslan; Burak Derkus; Emel Emregul; Kaan C Emregul
Journal:  Colloids Surf B Biointerfaces       Date:  2017-03-18       Impact factor: 5.268

Review 6.  Engineering extracellular matrix through nanotechnology.

Authors:  Cassandra M Kelleher; Joseph P Vacanti
Journal:  J R Soc Interface       Date:  2010-09-22       Impact factor: 4.118

Review 7.  Decellularized scaffolds as a platform for bioengineered organs.

Authors:  Luis F Tapias; Harald C Ott
Journal:  Curr Opin Organ Transplant       Date:  2014-04       Impact factor: 2.640

Review 8.  An overview of tissue and whole organ decellularization processes.

Authors:  Peter M Crapo; Thomas W Gilbert; Stephen F Badylak
Journal:  Biomaterials       Date:  2011-02-05       Impact factor: 12.479

Review 9.  Biodegradable synthetic polymers for tissue engineering.

Authors:  P A Gunatillake; R Adhikari
Journal:  Eur Cell Mater       Date:  2003-05-20       Impact factor: 3.942

Review 10.  Neural tissue engineering: strategies for repair and regeneration.

Authors:  Christine E Schmidt; Jennie Baier Leach
Journal:  Annu Rev Biomed Eng       Date:  2003       Impact factor: 9.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.